A study presented at American Headache Society Annual Scientific Meeting; June 19-22, 2025; Minneapolis has revealed that ...

Treatment needs vary among patients with cluster headache, according to a poster presented at the American Headache Society ...

Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

Television is always in season these days. It can be a distraction from the world’s ills, transporting us back in time or ...

Television is always in season these days. It can be a distraction from the world’s ills, transporting us back in time or immersing us in the first blush of young love; it can also help us work ...

June is Migraine Awareness Month, a time to shed light on one of the most common and often misunderstood neurological ...

Learn more about services at Mayo Clinic.About this study The purpose of this study is to compare whether anesthetizing multiple peripheral nerves of the scalp in the distribution of acute migraine ...

Among children and adolescents with episodic migraine, fremanezumab significantly reduced monthly migraine days.

You can differentiate them through the frequency and intensity of when they arise: Episodic migraines take place between one to 14 times every month. Chronic migraines occur 15 or more days a month ...

Final results from the Phase IV PEARL trial show that 66% of patients treated with Ajovy for episodic migraine and more than ...

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated statistically significant ...

Once-daily rimegepant 75 mg is effective and well-tolerated for short-term prevention of fasting-related headache in adults ...